Abstracts (HTML) List of Authors

Maciel, AL

Unravelling the recombinome of IKZF1 deletions in B-ALL

Maksymenko, K

De novo design of cytokines, antikines, and novokines
De novo design of growth factor inhibiting proteins

Malouf, C

Novel therapeutic avenues for MLL-AF4+ pro-B ALL patients based on a unique microRNA expression signature

Manhart, G

Identification of direct target genes of NUP98-KDM5A reveals regulatory gene networks in Acute Myeloid Leukemia

Mann, M

The proteogenomic subtypes of acute myeloid leukemia

Mansour, MR

Establishing the mechanism for RUVBL2 essentiality in acute myeloid leukaemia

Mardan, J

HiPSC disease modelling to study leukemia development in HAX1 vs ELANE associated congenital neutropenia

Marschalek, R

Designing specific chromosomal translocations of the MLL/KMT2A gene
MLL-r fusion transcripts in healthy individuals by induced gene proximity
Unravelling the recombinome of IKZF1 deletions in B-ALL
The immune checkpoint ICOSLG is a relapse-predicting biomarker and therapeutic target in infant t(4;11) ALL

Martens, JHA

Establishing the mechanism for RUVBL2 essentiality in acute myeloid leukaemia

Martínez, A

Contribution of aneuploidy to the initiation and progression of childhood B-cell acute lymphoblastic leukemia

Maschan, A

A new inherited syndrome with severe neutropenia and neurological involvement due to autosomal recessive COPZ1 mutation

Mätzig, T

CRISPR/Cas9-based generation of CAR-expressing natural killer-like cells against acute myeloid leukemia
A multifunctional tracking approach to study clonal heterogeneity in leukemia by flow cytometry and scRNA-seq

Mayar, A

A meningeal preleukemic niche promotes the homing of B-cell Precursor Acute Lymphoblastic Leukaemia cells to the CNS

McKenzie, L

Ex vivo and in vivo complex drug combination analysis for improved efficacy and specificity in high-risk childhood acute lymphoblastic leukaemia

Mde Álava, E

An innovative tailored CAR-T cell-redirecting immunotherapy for the treatment of metastatic and refractory Ewing Sarcoma

Meier, K

Identifying gene targets for drug repurposing to preventing myeloid malignancies

Menendez, P

An innovative tailored CAR-T cell-redirecting immunotherapy for the treatment of metastatic and refractory Ewing Sarcoma
Contribution of aneuploidy to the initiation and progression of childhood B-cell acute lymphoblastic leukemia
A single-cell expression atlas of human AML-LScs unravels the contribution of HIF pathway and its therapeutic potential
A new T cell-redirecting strategy for the treatment of relapse/refractory T cell acute lymphoblastic leukemia

Menge, K

Deciphering the molecular mechanism of NUP98-KDM5A chromosomal translocation in pediatric non-DS-AMKL

Mercher, T

Functional characterization of aberrant GATA1 protein complexes in normal and leukemic human erythroblasts

Merker, M

ErbB2-CAR mediated immunotherapy for the treatment of high-risk rhabdomyosarcoma

Mertlitz, S

High antileukemic efficiency of CD19-CAR NK cells engineered with Sleeping Beauty transposon vectors

Metzeler, K

Mutations in KRAS and DNMT3A are not related to dependency in established tumors, in PDX acute leukemia model in vivo

Metzler, M

Targeting metabolism effectively complements tyrosine kinase inhibitor treatment of chronic myeloid leukemia
CtDNA release mechanisms in a therapeutic Ewing Sarcoma mouse model
Comprehensive bone marrow analysis integrating deep learning-based pattern discovery (BMDeep)

Meyer, C

Unravelling the recombinome of IKZF1 deletions in B-ALL
The immune checkpoint ICOSLG is a relapse-predicting biomarker and therapeutic target in infant t(4;11) ALL

Meyer, J

CRISPR/Cas9-based generation of CAR-expressing natural killer-like cells against acute myeloid leukemia

Miriam, E

Prevention of relapse in juvenile myelomonocytic leukemia (JMML) by inhibition of immune checkpoint CD47

Miskey, C

High antileukemic efficiency of CD19-CAR NK cells engineered with Sleeping Beauty transposon vectors

Möker, N

Primary CD33-targeting CAR-NK cells for the treatment of acute myeloid leukemia

Molina, O

Contribution of aneuploidy to the initiation and progression of childhood B-cell acute lymphoblastic leukemia
A single-cell expression atlas of human AML-LScs unravels the contribution of HIF pathway and its therapeutic potential

Molnar, C

Identification of functional defects promoting leukemogenesis in GATA2-deficient individuals

Möricke, A

Prognostic significance of minimal residual disease prior to reinduction in intermediate risk patients with ALL
IKZF1plus under investigation: Optical Genome Mapping to detect additional alterations
Prognostic relevance of persisting minimal residual disease in children with ALL and slow early response to chemotherapy

Moser, LM

ErbB2-CAR mediated immunotherapy for the treatment of high-risk rhabdomyosarcoma

Mougiakaos, D

Targeting metabolism effectively complements tyrosine kinase inhibitor treatment of chronic myeloid leukemia

Müller, P

De novo design of growth factor inhibiting proteins

Münch, G

A meningeal preleukemic niche promotes the homing of B-cell Precursor Acute Lymphoblastic Leukaemia cells to the CNS